by Elec23 | Aug 23, 2024 | News&events
A new study suggests that antibodies produced by vaccinia-based vaccines may neutralize the Monkeypox virus, suggesting potential cross-protection against new threats. The findings emphasize VisMederi’s capability to aid in vaccine development and research...
by Elec23 | Aug 7, 2024 | News&events
VisMederi has been successfully qualified by Qualifyze for conducting activities according to GCLP (Good Clinical Laboratory Practices). Both our laboratory facilities have achieved the prestigious SILVER rating! This outstanding result once again reflects our utmost...
